Education
About Us
Working with TipRanks
Follow Us
EFAV - ETF AI Analysis
Top Page
iShares MSCI EAFE Min Vol Factor ETF (EFAV)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains this year, indicating strong overall momentum.
Global Diversification
The fund is spread across multiple countries, reducing reliance on any single geographic market.
Low Expense Ratio
With a competitive expense ratio, the ETF minimizes costs for investors compared to similar funds.
Negative Factors
Underperforming Top Holdings
Some major holdings, like Unilever and Shell, have shown weaker year-to-date performance, which may drag on returns.
Sector Concentration in Financials
The ETF has significant exposure to the financial sector, making it vulnerable to downturns in that industry.
Limited U.S. Exposure
The fund has minimal exposure to U.S. companies, which could limit its ability to benefit from strong U.S. market performance.
EFAV vs. SPDR S&P 500 ETF (SPY)
AUM5.25B
RegionDeveloped Markets
Expense Ratio0.20%
Beta0.32
IssueriShares
Inception DateOct 18, 2011
Dividend Yield3.16%
Asset ClassEquity
Index TrackedMSCI EAFE Minimum Volatility (USD)
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume392,499
30 Day Avg. Volume405,812
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
92.45Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering237
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFAV Summary
The iShares MSCI EAFE Min Vol Factor ETF (EFAV) is an investment fund that focuses on international stocks from developed markets like Europe, Japan, and Australia, aiming to reduce volatility. It tracks the MSCI EAFE Minimum Volatility Index and includes well-known companies such as Novartis and Unilever. This ETF is ideal for investors seeking stability and diversification in their portfolio while still benefiting from global growth opportunities. However, new investors should be aware that while EFAV aims to minimize volatility, it can still be affected by overall market trends and economic conditions in the regions it covers.
How much will it cost me?The iShares MSCI EAFE Min Vol Factor ETF (EFAV) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than the average for actively managed funds because EFAV is passively managed, tracking an index that focuses on minimizing volatility in developed markets outside North America.
What would affect this ETF?The EFAV ETF could benefit from stable economic growth in developed markets outside North America, particularly in sectors like financials, consumer defensive, and healthcare, which are well-represented in its portfolio. However, it may face challenges from rising interest rates, which could impact financial stocks, or geopolitical tensions in Europe and Asia that might affect market stability. Regulatory changes in these regions or shifts in global trade policies could also influence the ETF's performance.
EFAV Top 10 Holdings
The EFAV ETF leans heavily on stability, with a focus on developed markets outside North America and a tilt toward defensive sectors like Financials and Consumer Defensive. Novartis and Zurich Insurance are rising stars, delivering steady gains thanks to strong fundamentals and solid dividend yields. Iberdrola is also shining, buoyed by bullish momentum despite its debt concerns. On the flip side, Swisscom and Shell are lagging, weighed down by bearish technical trends and revenue challenges. Overall, the fund’s diversified approach offers a smoother ride, but its concentration in low-volatility names may limit upside in more aggressive market conditions.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 1.61% | $83.82M | CHF217.88B | 29.42% | 80 Outperform | |
| DBS Group Holdings | 1.58% | $82.22M | S$167.00B | 51.72% | 78 Outperform | |
| Iberdrola | 1.48% | $77.31M | €120.76B | 37.97% | 67 Neutral | |
| ORANGE SA | 1.47% | $76.75M | €38.85B | 43.26% | 65 Neutral | |
| Swisscom AG | 1.46% | $76.25M | CHF30.82B | 16.10% | 67 Neutral | |
| Zurich Insurance Group | 1.43% | $74.84M | CHF82.35B | 22.68% | 78 Outperform | |
| Takeda Pharmaceutical Co | 1.42% | $74.18M | ¥8.20T | 26.92% | 66 Neutral | |
| ― | 1.33% | $69.13M | ― | ― | ― | |
| Shell (UK) | 1.31% | $68.47M | £155.95B | 1.18% | 73 Outperform | |
| Koninklijke Ahold Delhaize N.V. | 1.31% | $68.39M | €29.55B | 0.08% | 62 Neutral |
EFAV Technical Analysis
Positive
―
Price Trends
85.49
Positive
84.66
Positive
82.75
Positive
Market Momentum
0.57
Positive
60.87
Neutral
79.86
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 86.76, equal to the 50-day MA of 85.49, and equal to the 200-day MA of 82.75, indicating a bullish trend. The MACD of 0.57 indicates Positive momentum. The RSI at 60.87 is Neutral, neither overbought nor oversold. The STOCH value of 79.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFAV.
EFAV Peer Comparison
Comparison Results
Performance Comparison
EFAV
iShares MSCI EAFE Min Vol Factor ETF
87.37
17.94
25.84%
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
BBIN
JPMorgan BetaBuilders International Equity ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents